Gentile, S. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf
2005; 28: 137–52.
Deering, S. Eating disorders: recognition, evaluation, and implications for obstetrician/gynecologists (1). Prim Care Update Ob Gyns
2001; 8: 31–5.
Lancet. Better news on population. Lancet
1992; 339: 1600.
Zuckerman, B, Amaro, H, Bauchner, H, Cabral, H. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol
1989; 160: 1107–11.
Cohen, LS, Altshuler, LL, Harlow, BL, Nonacs, R, Newport, DJ, Viguera, AC, Suri, R, Burt, VK, Hendrick, V, Reminick, AM, Loughead, A, Vitonis, AF, Stowe, ZN. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA
2006; 295: 499–507.
Berard, A, Ramos, E, Rey, E, Blais, L, St-Andre, M, Oraichi, D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol
2007; 80: 18–27.
Chambers, CD, Hernandez-Diaz, S, Van Marter, LJ, Werler, MM, Louik, C, Jones, KL, Mitchell, AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med
2006; 354: 579–87.
Kallen, B, Otterblad Olausson, P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol
2006; 21: 221–2.
Kulin, NA, Pastuszak, A, Sage, SR, Schick-Boschetto, B, Spivey, G, Feldkamp, M, Ormond, K, Matsui, D, Stein-Schechman, AK, Cook, L, Brochu, J, Rieder, M, Koren, G. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA
1998; 279: 609–10.
Pastuszak, A, Schick-Boschetto, B, Zuber, C, Feldkamp, M, Pinelli, M, Sihn, S, Donnenfeld, A, McCormack, M, Leen-Mitchell, M, Woodland, C, Gardner, A, Horn, M, Koren, G. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA
1993; 269: 2246–8.
Goldstein, DJ, Corbin, LA, Sundell, KL. Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol
1997; 89: 713–8.
Einarson, TR, Einarson, A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf
2005; 14: 823–7.
Kinney, DK, Yurgelun-Todd, DA, Levy, DL, Medoff, D, Lajonchere, CM, Radford-Paregol, M. Obstetrical complications in patients with bipolar disorder and their siblings. Psychiatry Res
1993; 48: 47–56.
Steer, RA, Scholl, TO, Hediger, ML, Fischer, RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol
1992; 45: 1093–9.
Orr, ST, Miller, CA. Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol Rev
1995; 17: 165–71.
Franko, DL, Blais, MA, Becker, AE, Delinsky, SS, Greenwood, DN, Flores, AT, Ekeblad, ER, Eddy, KT, Herzog, DB. Pregnancy complications and neonatal outcomes in women with eating disorders. Am J Psychiatry
2001; 158: 1461–6.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-9).
Régie de l'Assurance Maladie du Québec. Annual Statistics.
Government of Quebec, 1997.
Ramos, E, Oraichi, D, Rey, E, Blais, L, Berard, A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG
2007; 114: 1055–64.
Ofori, B, Rey, E, Berard, A. Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol
2007; 64: 496–509.
Martel, MJ, Rey, E, Beauchesne, MF, Perreault, S, Lefebvre, G, Forget, A, Blais, L. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ
2005; 330: 230.
Blais, L, Beauchesne, MF, Rey, E, Malo, JL, Forget, A. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax
2007; 62: 320–8.
Tamblyn, R, Lavoie, G, Petrella, L, Monette, J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol
1995; 48: 999–1009.
Levy, AR, Mayo, NE, Grimard, G. Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981–1992. Am J Epidemiol
1995; 142: 428–36.
Chambers, CD, Johnson, KA, Dick, LM, Felix, RJ, Jones, KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med
1996; 335: 1010–5.
Bonari, L, Koren, G, Einarson, TR, Jasper, JD, Taddio, A, Einarson, A. Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health
2005; 8: 214–20.
Louik, C, Lin, AE, Werler, MM, Hernandez-Diaz, S, Mitchell, AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med
2007; 356: 2675–83.
Alwan, S, Reefhuis, J, Rasmussen, SA, Olney, RS, Friedman, JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med
2007; 356: 2684–92.
Paganini-Hill, A, Ross, RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol
1982; 116: 114–22.
Tilley, BC, Barnes, AB, Bergstralh, E, Labarthe, D, Noller, KL, Colton, T, Adam, E. A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol
1985; 121: 269–81.
Van den Brandt, PA, Petri, H, Dorant, E, Goldbohm, RA, Van de Crommert, S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci
1991; 13: 91–6.
West, SL, Savitz, DA, Koch, G, Strom, BL, Guess, HA, Hartzema, A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol
1995; 142: 1103–12.
De Jong van den Berg, LT, Feenstra, N, Sorensen, HT, Cornel, MC. Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. European Medicine and Pregnancy Group. Teratology
1999; 60: 33–6.
Banhidy, F, Lowry, RB, Czeizel, AE. Risk and benefit of drug use during pregnancy. Int J Med Sci
2005; 2: 100–6.
International Clearinghouse for Birth Defects Monitoring Systems. Annual Report.
Murphy, JM, Olivier, DC, Monson, RR, Sobol, AM, Federman, EB, Leighton, AH. Depression and anxiety in relation to social status. A prospective epidemiologic study. Arch Gen Psychiatry
1991; 48: 223–9.